The dual effect of a nitric oxide donor in nociception

Brain Research

Volumn 897, Issue 1-2, 2001, Pages 9-19

  Sousa, Angela M ^a   Prado, Wiliam A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

1H 1,2,4 Oxadiazolo 4,3 a quinoxalin 1 one; Chronic constriction nerve injury; NG Nitro L arginine; Nitric oxide; Tail flick test

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; GUANYLATE CYCLASE; HEMOGLOBIN; LINSIDOMINE; N(G) METHYLARGININE; N(G) NITROARGININE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; LATENT PERIOD; MALE; MECHANICAL STIMULATION; NERVE INJURY; NERVE LIGATION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SCIATIC NERVE; TAIL FLICK TEST; WITHDRAWAL REFLEX;

ANIMALS; CHRONIC DISEASE; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEMOGLOBINS; INJECTIONS, SPINAL; LIGATION; MALE; MOLSIDOMINE; NERVE COMPRESSION SYNDROMES; NEURALGIA; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROARGININE; NOCICEPTORS; OMEGA-N-METHYLARGININE; OXADIAZOLES; PAIN MEASUREMENT; QUINOXALINES; RATS; RATS, WISTAR; SCIATIC NERVE;

EID: 0035815485     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)01995-3     Document Type: Article

References (70)

1. Nitric oxide signaling in pain and nociceptor sensitization in the rat
2. G-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: Trouble in paradise
3. Nitric oxide activates guanylate cyclase and increases guanosine-3′,5′-monophosphate levels in various tissue preparations
4. Feedback inhibition of nitric oxide synthase activity by nitric oxide
5. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: Dissociation between the effect of L-NAME and L-NMMA
6. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in men
7. Local transdermal glyceryl trinitrate has an antiinflammatory action on thrombophlebitis induced by sclerosis of leg varicose veins
8. Successful treatment of shoulder pain syndrome due to supraspinatus tendinitis with transdermal nitroglycerin. A double blind study
9. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
10. The controversy about spinal neuronal nitric oxide synthase: Under which conditions is it up- or downregulated?
11. 2+ channel currents in rat sympathetic neurons
12. Neuropathic pain in rats is associated with altered nitric oxide synthase activity in neural tissue
13. 2+ currents through a mechanism independent of cGMP-dependent protein kinase
14. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway
15. Nitric oxide synthase immunoreactivity in rat spinal cord
16. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord
17. The use of nitric oxide donors in pharmacological studies
18. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo-[4,3,-a]quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation
19. On the mechanism of NO release from sydnonimines
20. The molecular mechanism of action of peripheral morphine analgesia: Stimulation of the cGMP system via nitric oxide release
21. Nitric oxide contributes to both spinal nociceptive transmission and its descending inhibition in rats: An immunocytochemical study
22. Carrageenan-induced inflammation alters the content of i-cGMP and i-cAMP in the dorsal horn of the spinal cord
23. Glutamate, nitric oxide and cell-cell signaling in the nervous system
24. Nitric oxide signaling in the central nervous system
25. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo-[4,3,-a]quinoxalin-1-one
26. Reorganization of the spinal dorsal horn in models of chronic pain: Correlation with behaviour
27. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test
28. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat
29. Treatment of a chronic allodynia-like response in spinally injured rats: Effects of systemically administered nitric oxide synthase inhibitors
30. Analgesic effect of L-arginine in patients with persistent pain
31. G-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine
32. Nitric oxide evokes pain in humans on intracutaneous injection
33. Nitric oxide: A novel signal transduction mechanism for transcellular communication
34. Intrathecal administration of a new nitric oxide donor, NOC-18, produces acute thermal hyperalgesia in the rat
35. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats
36. Antinociceptive effect of L-arginine on the carrageenan-induced hyperalgesia of the rat: Possible involvement of central opioidergic systems
37. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: A dual role of peripherally formed NO in pain modulation
38. L-Leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenan-induced hyperalgesia
39. Nitric oxide as a chemical link in the generation of pain from veins in humans
40. Nitric oxide and arachidonic acid modulation of calcium currents in postganglionic neurones of cultured avian ciliary ganglia
41. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management
42. Involvement of cGMP in nociceptive processing by and sensitization of spinothalamic neurons in primates
43. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord
44. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats
45. The enigma of potassium ion in the management of dentin hypersensitivity: Is nitric oxide the elusive second messenger?
46. Nitric oxide (NO) and nociceptive processing in the spinal cord
47. Is there a role for endothelium-derived relaxing factor in nociception?
48. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat
49. 2+ current
50. The induction of pain: An integrative review
51. G-Nitro arginine methyl ester exhibits antinociceptive activity in the mouse
52. Involvement of endogenous nitric oxide in the mechanism of bradykinin-induced peripheral hyperalgesia
53. Crossover study of glyceryl trinitrate patches for controlling pain in women with severe dysmenorrhoea
54. 3H] dopamine uptake
55. Involvement of the nitric oxide pathway in nociceptive processes in the central nervous system in rats
56. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord
57. Nitric oxide donors reversibly block axonal conduction: Demyelinated axons are especially susceptible
58. Regulation of nitric oxide synthase by nitric oxide
59. A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation
60. Nitric oxide expression and regulation in the dorsal root ganglion and spinal cord
61. Rat spinal cord neurons contain nitric oxide synthase
62. Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase
63. + channels: Mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside
64. Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices
65. A novel clinical treatment of persistent pain with L-arginine
66. Nitric oxide: A radical neurotransmitter in the central nervous system
67. Activation of a NO-cyclic GMP system by NO donors potentiates β-endorphin-induced antinociception in the mouse
68. Nitric oxide in the rat spinal cord in Freund's adjuvant-induced hyperalgesia
69. Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission
70. Ethical guidelines for investigations of experimental pain in conscious animals